468 related articles for article (PubMed ID: 19020659)
1. c-Myc is required for maintenance of glioma cancer stem cells.
Wang J; Wang H; Li Z; Wu Q; Lathia JD; McLendon RE; Hjelmeland AB; Rich JN
PLoS One; 2008; 3(11):e3769. PubMed ID: 19020659
[TBL] [Abstract][Full Text] [Related]
2. Targeting cancer stem cells through L1CAM suppresses glioma growth.
Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
[TBL] [Abstract][Full Text] [Related]
3. Brain cancer stem cells display preferential sensitivity to Akt inhibition.
Eyler CE; Foo WC; LaFiura KM; McLendon RE; Hjelmeland AB; Rich JN
Stem Cells; 2008 Dec; 26(12):3027-36. PubMed ID: 18802038
[TBL] [Abstract][Full Text] [Related]
4. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
5. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
Kim EJ; Kim SH; Jin X; Jin X; Kim H
Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
[TBL] [Abstract][Full Text] [Related]
6. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
7. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.
Patru C; Romao L; Varlet P; Coulombel L; Raponi E; Cadusseau J; Renault-Mihara F; Thirant C; Leonard N; Berhneim A; Mihalescu-Maingot M; Haiech J; Bièche I; Moura-Neto V; Daumas-Duport C; Junier MP; Chneiweiss H
BMC Cancer; 2010 Feb; 10():66. PubMed ID: 20181261
[TBL] [Abstract][Full Text] [Related]
8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive in vivo imaging of tumor-associated CD133/prominin.
Tsurumi C; Esser N; Firat E; Gaedicke S; Follo M; Behe M; Elsässer-Beile U; Grosu AL; Graeser R; Niedermann G
PLoS One; 2010 Dec; 5(12):e15605. PubMed ID: 21187924
[TBL] [Abstract][Full Text] [Related]
10. An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells.
Gil-Ranedo J; Mendiburu-Eliçabe M; García-Villanueva M; Medina D; del Álamo M; Izquierdo M
PLoS One; 2011; 6(12):e28753. PubMed ID: 22174890
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
12. Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
Kim MJ; Kim RK; Yoon CH; An S; Hwang SG; Suh Y; Park MJ; Chung HY; Kim IG; Lee SJ
J Cell Sci; 2011 Sep; 124(Pt 18):3084-94. PubMed ID: 21878493
[TBL] [Abstract][Full Text] [Related]
13. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
[TBL] [Abstract][Full Text] [Related]
14. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
[TBL] [Abstract][Full Text] [Related]
15. Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
Arun S; Ravisankar S; Vanisree AJ
J Neurooncol; 2017 Dec; 135(3):473-485. PubMed ID: 28875331
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
[TBL] [Abstract][Full Text] [Related]
17. Biology of glioma cancer stem cells.
Park DM; Rich JN
Mol Cells; 2009 Jul; 28(1):7-12. PubMed ID: 19655094
[TBL] [Abstract][Full Text] [Related]
18. ACYP2 contributes to malignant progression of glioma through promoting Ca
Li M; Ruan B; Wei J; Yang Q; Chen M; Ji M; Hou P
J Exp Clin Cancer Res; 2020 Jun; 39(1):106. PubMed ID: 32517717
[TBL] [Abstract][Full Text] [Related]
19. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
[TBL] [Abstract][Full Text] [Related]
20. Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression.
Huang H; Yu X; Han X; Hao J; Zhao J; Bebek G; Bao S; Prayson RA; Khalil AM; Jankowsky E; Yu JS
Cell Rep; 2021 Jan; 34(1):108522. PubMed ID: 33406417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
